Although this population is more prevalent in Vκ*MYC mice (mean 12.9 ± 7.7%, Supplementary Fig. 6a), similar ranges have been observed in MM patients, with higher proliferative indexes correlating to worse outcomes41. The gene discussed is MYC; the disease is Miyoshi myopathy.